What we should choose for the A/B testing measurement? T test or linear regression? What's the difference and why so simple approach as linear regression reallyWhat we should choose for the A/B testing measurement? T test or linear regression? What's the difference and why so simple approach as linear regression really

How to Build Connections for A/B Testing and Linear Regression: An Essential Guide

2026/01/08 05:51
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Linear regression or T-test. How to choose?

\ We often get caught up in the buzz around fancy machine learning models and deep learning breakthroughs, but let’s not overlook the humble linear regression.

\ ==In a world of LLM and cutting-edge architectures, linear regression quietly plays a crucial role, and it’s time we shine a light on how it can be beneficial even today.==

\ Consider a scenario where an e-commerce company introduces a new banner, and we aim to assess the impact of it on the average session length. To achieve this, an experiment was conducted, and data was gathered for analysis. Let’s analyze the results.

T-test

Let’s employ a familiar tool for this task: the t-test.

The results are pretty promising:

The uplift in the metric is simply the difference between the sample averages of the control and treatment groups. In our case, the estimated uplift is 0.56 minutes, indicating that users, on average, spend 33 seconds longer using our product.

Linear Regression

Now, let’s employ linear regression with the treatment vector (whether the new banner is shown or not) as the independent variable and the average session length as the output variable.

Then we print the summary of our model:

\

\ Notably, the coefficient for the treatment variable aligns with our earlier uplift estimate of 0.56. It is worth noting that R-squared is just 0.008, and we don’t explain too much of the variance with this model.

Coincidence?

Is this a coincidence that the uplift we got from the t-test and the treatment coefficient are the same? Let’s delve into the connection.

\ Let’s think about what the treatment variable reflects. When it equals 1, it indicates the average session length for users who viewed the banner; when it equals 0, it indicates the average session length for users who did not see the banner. It means the treatment variable (or slope in linear regression terms) signifies the change in mean between the control and treatment groups.

What is the null hypothesis for the treatment variable in linear regression?

What is the null hypothesis when we apply the T-test for the experiment? It’s totally the same.

Hence, when computing the t-statistics and p-value for identical hypotheses, our findings remain consistent and identical.

Why do we want to use linear regression?

However, what is the reason behind using linear regression? We do not want to just overcomplicate things.

\ First, let’s think about whether only the treatment is responsible for the change in our primary metric.

\ In reality, this may not be entirely accurate due to the presence of selection bias.

\ Selection bias in A/B testing is a type of error when there is a systematic difference between the groups being compared that is not due to random chance, for example:

\

  • We witness that old users get exposed to a new banner more often than new customers.

    \

Random allocation that we use in AB tests helps us to mitigate it, but it’s hard to eliminate completely.

\ Let’s formulate how to estimate the true effect.

ATE: average treatment effect that we aim to estimate.

\ ATT: average treatment effect of those treated. We can also call it ACE: average causal effect. We actually can calculate it. It is the difference between the sample averages of the control and treatment groups.

\ SB: selection bias that we aim to minimize.

\ How can we minimize it?

\ Linear regression allows us to add covariates/confounding variables. Let’s try it out and add as one of confounding variable the average session length for users before the experiment.

And print the summary of the model:

Our R-squared has skyrocketed! Now, we explain 86% of the variance.

\ Our treatment effect now is 0.47.

Which one to choose?

So, we have two treatment effects: 0.47 and 0.56; which one is correct?

\ In this case, we know for sure the true effect because I have simulated data and the real uplift: 0.5

import numpy as np import pandas as pd from scipy import stats import statsmodels.api as sm np.random.seed(45) n = 500 x = np.random.normal(loc = 10 ,scale = 3, size= 2 * n) y = x + np.random.normal(loc = 2 , scale = 1 ,size = len(x)) # For 50% of users we simulate treatment effect treat = 1 * (np.random.rand(2 * n) <= 0.5) experiment = pd.DataFrame(x, columns=["covariate"]) experiment['metric'] = y experiment['treatment'] = treat experiment['noise'] = np.random.normal(size = len(experiment)) # Add noise and uplift to 'metric' for rows where 'treat' is equal to 1 # The real uplift is 0.5 experiment['metric'] = experiment.apply(lambda row: row['metric'] + 0.5 * row['treatment'] + row['noise'] if row['treatment'] == 1 else row['metric'], axis=1)

That means 0.47 is better in terms of absolute difference and is closer to reflecting the actual uplift.

Conclusion

Using linear regression has the following advantages:

  1. It provides a deeper comprehension of our data and how well the model aligns with the data.
  2. By using covariates, we can mitigate selection bias, resulting in a more accurate estimation of the treatment effect.

\ Can we use linear regression for other tests, like the Welch t-test or the Chi-square test?

\ The simple answer is yes. However, we have to make some adjustments that we are going to discuss in the next articles!

Market Opportunity
B Logo
B Price(B)
$0.21501
$0.21501$0.21501
-3.24%
USD
B (B) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XRP Price News: Elon Musk Confirms X Money Crypto Plans as Pepeto’s Three Products Approach Launch and the 537x Window Stays Open

XRP Price News: Elon Musk Confirms X Money Crypto Plans as Pepeto’s Three Products Approach Launch and the 537x Window Stays Open

Elon Musk just told the world that X Money is adding crypto. When a platform with hundreds of millions of users integrates cryptocurrency, the market pays attention
Share
Techbullion2026/03/07 08:37
What should investors expect from the Federal Reserve after latest jobs data?

What should investors expect from the Federal Reserve after latest jobs data?

Investors looking at the Federal Reserve after the latest jobs data got a rough answer on Friday. The labor market is getting weaker, inflation is still above the
Share
Cryptopolitan2026/03/07 08:20
Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

The post Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &nbsp &nbsp Forward Industries, the largest publicly traded Solana treasury company, has filed a $4 billion at-the-market (ATM) equity offering program with the U.S. SEC  to raise more capital for additional SOL accumulation. Forward Strategies Doubles Down On Solana Strategy In a Wednesday press release, Forward Industries revealed that the 4 billion ATM equity offering program will allow the company to issue and sell common stock via Cantor Fitzgerald under a sales agreement dated Sept. 16, 2025. Forward said proceeds will go toward “general corporate purposes,” including the pursuit of its Solana balance sheet and purchases of income-generating assets. The sales of the shares are covered by an automatic shelf registration statement filed with the US Securities and Exchange Commission that is already effective – meaning the shares will be tradable once they’re sold. An automatic shelf registration allows certain publicly listed companies to raise capital with flexibility swiftly.  Kyle Samani, Forward’s chairman, astutely described the ATM offering as “a flexible and efficient mechanism” to raise and deploy capital for the company’s Solana strategy and bolster its balance sheet.  Advertisement &nbsp Though the maximum amount is listed as $4 billion, the firm indicated that sales may or may not occur depending on existing market conditions. “The ATM Program enhances our ability to continue scaling that position, strengthen our balance sheet, and pursue growth initiatives in alignment with our long-term vision,” Samani said. Forward Industries kicked off its Solana treasury strategy on Sept. 8. The Wednesday S-3 form follows Forward’s $1.65 billion private investment in public equity that closed last week, led by crypto heavyweights like Galaxy Digital, Jump Crypto, and Multicoin Capital. The company started deploying that capital this week, announcing it snatched up 6.8 million SOL for approximately $1.58 billion at an average price of $232…
Share
BitcoinEthereumNews2025/09/18 03:42